Now showing items 1-2 of 2

    • Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure. 

      AbouEzzeddine, OF; Anstrom, Kevin J; Bart, BA; Braunwald, E; DeVore, Adam David; Felker, G Michael; Goldsmith, SR; ... (16 authors) (JACC Heart Fail, 2015-02)
      OBJECTIVES: The purpose of this study was to assess the relationship between biomarkers of renin-angiotensin-aldosterone system (RAAS) activation and decongestion strategies, worsening renal function, and clinical outcomes. ...
    • Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital. 

      Anstrom, Kevin J; Buggey, J; DeVore, Adam David; Eisenstein, EL; Ersbøll, MK; Fiuzat, M; Mentz, Robert John; ... (10 authors) (J Cardiovasc Pharmacol, 2015-05)
      Furosemide has historically been the primary loop diuretic in heart failure patients despite data suggesting potential advantages with torsemide. We used the Duke Echocardiography Lab Database to investigate patients admitted ...